News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
385,094 Results
Type
Article (19061)
Company Profile (165)
Press Release (365868)
Section
Business (116842)
Career Advice (1671)
Deals (21627)
Drug Delivery (68)
Drug Development (53329)
Employer Resources (59)
FDA (9704)
Job Trends (8558)
News (206636)
Policy (19307)
Tag
Academia (1040)
Alliances (29800)
Alzheimer's disease (755)
Approvals (9734)
Artificial intelligence (99)
Bankruptcy (191)
Best Places to Work (6600)
Biotechnology (78)
Breast cancer (139)
Cancer (1007)
Cardiovascular disease (74)
Career advice (1322)
Cell therapy (141)
Clinical research (44161)
Collaboration (338)
Compensation (155)
COVID-19 (1106)
C-suite (75)
Data (1027)
Diabetes (104)
Diagnostics (2981)
Earnings (45091)
Events (56814)
Executive appointments (307)
FDA (10216)
Funding (273)
Gene therapy (126)
GLP-1 (374)
Government (2077)
Healthcare (7915)
Infectious disease (1155)
Interviews (275)
IPO (9602)
Job creations (2338)
Job search strategy (1211)
Layoffs (201)
Legal (4457)
Lung cancer (161)
Lymphoma (79)
Manufacturing (148)
Medical device (4926)
Medtech (4928)
Mergers & acquisitions (12218)
Metabolic disorders (278)
Neuroscience (964)
NextGen Class of 2024 (2757)
Non-profit (1467)
Northern California (1121)
Obesity (149)
Opinion (123)
Patents (87)
People (35821)
Pharmaceutical (79)
Phase I (12501)
Phase II (19114)
Phase III (15798)
Pipeline (358)
Postmarket research (1774)
Preclinical (5092)
Radiopharmaceuticals (157)
Rare diseases (170)
Real estate (3292)
Regulatory (13715)
Research institute (1071)
Resumes & cover letters (294)
Southern California (890)
Startups (2003)
United States (9277)
Vaccines (237)
Weight loss (92)
Date
Last 7 days (121)
Last 30 days (1179)
Last 365 days (21585)
2025 (63)
2024 (21964)
2023 (23383)
2022 (30932)
2021 (32113)
2020 (30031)
2019 (24259)
2018 (18677)
2017 (20043)
2016 (18478)
2015 (21884)
2014 (16960)
2013 (14012)
2012 (15376)
2011 (16247)
2010 (14424)
Location
Africa (523)
Arizona (68)
Asia (27510)
Australia (4016)
California (2431)
Canada (998)
China (243)
Colorado (111)
Connecticut (133)
Delaware (73)
Europe (58659)
Florida (334)
Illinois (212)
Indiana (142)
Japan (80)
Maryland (365)
Massachusetts (1854)
Michigan (69)
Minnesota (117)
New Jersey (778)
New York (693)
North Carolina (440)
Northern California (1121)
Ohio (83)
Pennsylvania (529)
South America (763)
Southern California (890)
Texas (354)
Virginia (76)
Washington State (195)
385,094 Results for "l e a f pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.
June 5, 2024
·
4 min read
Press Releases
BioTalent Canada Announces First Recipients of the I.D.E.A.L. Scholarship™
September 24, 2024
·
4 min read
Business
Alkeus Pharmaceuticals Appoints Eric L. Trachtenberg as Chief Legal Officer
Alkeus Pharmaceuticals, Inc. today announced that Eric L. Trachtenberg, J.D., M.B.A., has joined the company as Chief Legal Officer.
May 29, 2024
·
2 min read
Press Releases
Boston Pharmaceuticals to Announce Positive Phase 2 Data on Efimosfermin Alfa (BOS-580) in F2/F3 MASH During Late-Breaking Oral Presentation at AASLD 2024, The Liver Meeting®
November 15, 2024
·
6 min read
Press Releases
Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises
December 30, 2024
·
4 min read
Press Releases
NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer
January 2, 2025
·
3 min read
Biotech Beach
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
Gyre Therapeutics today announced that the Center for Drug Evaluation (“CDE”) of China’s National Medical Products Administration (“NMPA”) has approved Gyre Pharmaceuticals’ (Gyre’s indirectly controlled subsidiary) Investigational New Drug (“IND”) application for F230 tablets.
May 30, 2024
·
3 min read
BioCapital
Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal
Telomir Pharmaceuticals, Inc. announced that Michael F. Roizen, MD, a leader in age-related medicine and an existing advisor to the Company, will be increasing his role in the coming months as a Special Advisor on Age Reversal.
March 5, 2024
·
5 min read
Drug Development
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
June 7, 2024
·
7 min read
Business
Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
Galmed Pharmaceuticals Ltd. announced that it has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission.
April 4, 2024
·
5 min read
1 of 38,510
Next
